Simultaneous screening for head and neck, lung cancers may improve early detection, survival
the ONA take:
According to a new analysis published in the journal Cancer, researchers from the University of Pittsburgh Cancer Institute in Pittsburgh, Pennsylvania, have found that screening patients for head and neck cancer and lung cancer could improve early detection and survival.
The multidisciplinary team analyzed data from 3,587 patients from the Pittsburgh Lung Screening Study (PLuSS) to investigate whether those patients, which included both current and ex-smokers, had a higher risk of developing head and neck cancer.
Results showed that the rate of head and neck cancer among the PLuSS participants was 71.4 cases annually per 100,000 people compared with the expected 43 cases annually per 100,000 in the general U.S. population.
Because head and neck cancer is rare in comparison to the most common cancer types, the researchers note that it would be impractical to screen the general population for the disease, but patients at risk for lung cancer that would be referred for lung cancer screening would most likely benefit from head and neck cancer screenings as well.
The researchers are now designing a national study to assess the effect of simultaneous lung and head and neck cancer screening on mortality.
Screening patients for head and neck cancer and lung cancer could improve early detection and survival.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|